{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T16:08:03Z","timestamp":1778947683219,"version":"3.51.4"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["2022A0301-417-01"],"award-info":[{"award-number":["2022A0301-417-01"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.lfs.2026.124358","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:49:06Z","timestamp":1774630146000},"page":"124358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Membrane protein-focused CRISPR screen identifies ATP2A2 as a druggable transcriptional co-regulator of CCND1 (cyclin D1) in lung adenocarcinoma"],"prefix":"10.1016","volume":"394","author":[{"given":"Yu","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihuang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lfs.2026.124358_bb0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin. Proc."},{"issue":"12","key":"10.1016\/j.lfs.2026.124358_bb0010","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","article-title":"Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung Cancer in the US","volume":"7","author":"Ganti","year":"2021","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.lfs.2026.124358_bb0015","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1378\/chest.12-2345","article-title":"Epidemiology of lung cancer diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"143","author":"Alberg","year":"2013","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.lfs.2026.124358_bb0020","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nrc2190","article-title":"Lung cancer in never smokers\u2014a different disease","volume":"7","author":"Sun","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"7114","key":"10.1016\/j.lfs.2026.124358_bb0025","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/bmj.315.7114.980","article-title":"The accumulated evidence on lung cancer and environmental tobacco smoke","volume":"315","author":"Hackshaw","year":"1997","journal-title":"Br. Med. J."},{"issue":"4","key":"10.1016\/j.lfs.2026.124358_bb0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.annonc.2022.12.009","article-title":"Oncogene-addicted metastatic non-small-cell lung cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Hendriks","year":"2023","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.lfs.2026.124358_bb0035","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1056\/NEJMra1703413","article-title":"Precision diagnosis and treatment for advanced non-small-cell lung cancer","volume":"377","author":"Reck","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"7689","key":"10.1016\/j.lfs.2026.124358_bb0040","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.lfs.2026.124358_bb0045","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","article-title":"Toward personalized treatment approaches for non-small-cell lung cancer","volume":"27","author":"Wang","year":"2021","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.lfs.2026.124358_bb0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-small cell lung cancer, version 4.2024","volume":"22","author":"Riely","year":"2024","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"7417","key":"10.1016\/j.lfs.2026.124358_bb0055","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature11404","article-title":"Comprehensive genomic characterization of squamous cell lung cancers","volume":"489","author":"Hammerman","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.lfs.2026.124358_bb0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.lfs.2026.124358_bb0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1158\/2159-8290.CD-15-0894","article-title":"Targeting CDK4 and CDK6: from discovery to therapy","volume":"6","author":"Sherr","year":"2016","journal-title":"Cancer Discov."},{"issue":"7283","key":"10.1016\/j.lfs.2026.124358_bb0070","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.lfs.2026.124358_bb0075","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-14-0816","article-title":"Molecular pathways: targeting the cyclin D-CDK4\/6 axis for cancer treatment","volume":"21","author":"VanArsdale","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.lfs.2026.124358_bb0080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1101\/gad.7.3.331","article-title":"Direct binding of cyclin-D to the retinoblastoma gene-product (Prb) and Prb phosphorylation by the cyclin D-dependent kinase CDK4","volume":"7","author":"Kato","year":"1993","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.lfs.2026.124358_bb0085","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/MCB.18.2.753","article-title":"Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-CDK complexes","volume":"18","author":"Lundberg","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2026.124358_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113676","article-title":"Multiple effects of CDK4\/6 inhibition in cancer: from cell cycle arrest to immunomodulation","volume":"170","author":"Bonelli","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2026.124358_bb0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ctrv.2016.03.002","article-title":"Targeting CDK4\/6 in patients with cancer","volume":"45","author":"Hamilton","year":"2016","journal-title":"Cancer Treat. Rev."},{"issue":"171","key":"10.1016\/j.lfs.2026.124358_bb0100","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0145-2023","article-title":"CDK4\/6 inhibitors in lung cancer: current practice and future directions","volume":"33","author":"Lv","year":"2024","journal-title":"Eur. Respir. Rev."},{"issue":"6","key":"10.1016\/j.lfs.2026.124358_bb0105","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","article-title":"Targeting CDK4 and CDK6 in cancer","volume":"22","author":"Goel","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.lfs.2026.124358_bb0110","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/cas.14419","article-title":"Abemaciclib induces atypical cell death in cancer cells characterized by formation of cytoplasmic vacuoles derived from lysosomes","volume":"111","author":"Hino","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lfs.2026.124358_bb0115","first-page":"13","article-title":"LY2874455 and abemaciclib reverse FGF3\/4\/19\/CCND1 amplification mediated gefitinib resistance in NSCLC","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2026.124358_bb0120","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.canlet.2017.08.031","article-title":"Palbociclib, a selective CDK4\/6 inhibitor, enhances the effect of selumetinib in RAS-driven non-small cell lung cancer","volume":"408","author":"Zhou","year":"2017","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.lfs.2026.124358_bb0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s43018-024-00893-z","article-title":"Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer","volume":"6","author":"Asciolla","year":"2025","journal-title":"Nat. Cancer"},{"issue":"16","key":"10.1016\/j.lfs.2026.124358_bb0130","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1038\/onc.2016.379","article-title":"Acquired CDK6 amplification promotes breast cancer resistance to CDK4\/6 inhibitors and loss of ER signaling and dependence","volume":"36","author":"Yang","year":"2017","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.lfs.2026.124358_bb0135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.molcel.2020.08.020","article-title":"Integrating old and new paradigms of G1\/S control","volume":"80","author":"Rubin","year":"2020","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.lfs.2026.124358_bb0140","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/0008-5472.CAN-15-0728","article-title":"Early adaptation and acquired resistance to CDK4\/6 inhibition in estrogen receptor-positive breast cancer","volume":"76","author":"Herrera-Abreu","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2026.124358_bb0145","first-page":"4","article-title":"Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer. NPJ","author":"Guarducci","year":"2018","journal-title":"Breast Cancer"},{"key":"10.1016\/j.lfs.2026.124358_bb0150","article-title":"Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens","volume":"568(7753):511\u2013+","author":"Behan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2026.124358_bb0155","article-title":"In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target","volume":"547(7664):413\u2013+","author":"Manguso","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2026.124358_bb0160","article-title":"In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target","volume":"184(21):5357\u2013+","author":"Wang","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.lfs.2026.124358_bb0165","article-title":"Surfaceome CRISPR screen identifies OLFML3 as a rhinovirus-inducible IFN antagonist","volume":"22","author":"Mei","year":"2021","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124358_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55261-3","article-title":"ALCAM is an entry factor for severe community acquired pneumonia-associated human adenovirus species B","volume":"15","author":"Xie","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2026.124358_bb0175","article-title":"EXTL3 and NPC1 are mammalian host factors for Autographa californica multiple nucleopolyhedrovirus infection","volume":"15","author":"Huang","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.lfs.2026.124358_bb0180","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20145216","article-title":"Measuring error rates in genomic perturbation screens: gold standards for human functional genomics","volume":"10","author":"Hart","year":"2014","journal-title":"Mol. Syst. Biol."},{"issue":"7","key":"10.1016\/j.lfs.2026.124358_bb0185","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.7150\/thno.52848","article-title":"PHB2 promotes tumorigenesis via RACK1 in non-small cell lung cancer","volume":"11","author":"Wu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2026.124358_bb0190","first-page":"8","article-title":"Small-molecule RL71-triggered excessive autophagic cell death as a potential therapeutic strategy in triple-negative breast cancer","author":"Gao","year":"2017","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.lfs.2026.124358_bb0195","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1016\/j.apsb.2022.05.009","article-title":"Highly expressed SERCA2 triggers tumor cell autophagy and is a druggable vulnerability in triple-negative breast cancer","volume":"12","author":"Fan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"8","key":"10.1016\/j.lfs.2026.124358_bb0200","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00000478-200608000-00006","article-title":"Sarco\/endoplasmic reticulum calcium-ATPase 2 expression as a tumor marker in colorectal cancer","volume":"30","author":"Chung","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124358_bb0205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0968-0004(97)01143-2","article-title":"The endoplasmic reticulum Ca2+ store: a view from the lumen","volume":"23","author":"Meldolesi","year":"1998","journal-title":"Trends Biochem. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2026.124358_bb0210","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.yjmcc.2009.11.012","article-title":"Multiple and diverse coexpression, location, and regulation of additional SERCA2 and SERCA3 isoforms in nonfailing and failing human heart","volume":"48","author":"Dally","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7172","key":"10.1016\/j.lfs.2026.124358_bb0215","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/nature06418","article-title":"The structural basis of calcium transport by the calcium pump","volume":"450","author":"Olesen","year":"2007","journal-title":"Nature"},{"issue":"3\u20134","key":"10.1016\/j.lfs.2026.124358_bb0220","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ceca.2005.06.033","article-title":"Modulating sarco(endo)plasmic reticulum Ca2+ ATPase 2 (SERCA2) activity: cell biological implications","volume":"38","author":"Vangheluwe","year":"2005","journal-title":"Cell Calcium"},{"issue":"33","key":"10.1016\/j.lfs.2026.124358_bb0225","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb0147","article-title":"Cryo-EM structures of SERCA2b reveal the mechanism of regulation by the luminal extension tail","volume":"6","author":"Zhang","year":"2020","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.lfs.2026.124358_bb0230","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00403-008-0910-x","article-title":"Novel mutations of the ATP2A2 gene in two families with Darier\u2019s disease","volume":"301","author":"Shi","year":"2009","journal-title":"Arch. Dermatol. Res."},{"issue":"1","key":"10.1016\/j.lfs.2026.124358_bb0235","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"Matthews","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2026.124358_bb0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ceca.2017.07.006","article-title":"Calcium signaling and cell cycle: progression or death","volume":"70","author":"Humeau","year":"2018","journal-title":"Cell Calcium"},{"issue":"23","key":"10.1016\/j.lfs.2026.124358_bb0245","doi-asserted-by":"crossref","first-page":"17344","DOI":"10.1074\/jbc.M000887200","article-title":"B-ind1, a novel mediator of Rac1 signaling cloned from sodium butyrate-treated fibroblasts","volume":"275","author":"Courilleau","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124358_bb0250","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/nu11102376","article-title":"Curcumin and cancer","volume":"11","author":"Giordano","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2026.124358_bb0255","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-10-12","article-title":"Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma","volume":"10","author":"Wilken","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lfs.2026.124358_bb0260","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.semcancer.2020.02.011","article-title":"Curcumin and colorectal cancer: an update and current perspective on this natural medicine","volume":"80","author":"Weng","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"8","key":"10.1016\/j.lfs.2026.124358_bb0265","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/1759-7714.13904","article-title":"Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy","volume":"12","author":"Tang","year":"2021","journal-title":"Thorac. Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2026.124358_bb0270","first-page":"1523","article-title":"Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K\/Akt\/mTOR pathway","volume":"39","author":"Liu","year":"2018","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2026.124358_bb0275","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canlet.2015.11.021","article-title":"Curcumin induces apoptosis by inhibiting sarco\/endoplasmic reticulum Ca2+ ATPase activity in ovarian cancer cells","volume":"371","author":"Seo","year":"2016","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.lfs.2026.124358_bb0280","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.biopha.2014.10.014","article-title":"Novel role of Sarco\/endoplasmic reticulum calcium ATPase 2 in development of colorectal cancer and its regulation by F36, a curcumin analog","volume":"68","author":"Fan","year":"2014","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.lfs.2026.124358_bb0285","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1158\/1535-7163.MCT-10-0812","article-title":"Targeting sarcoplasmic\/endoplasmic reticulum Ca2+ ATPase 2 by curcumin induces ER stress-associated apoptosis for treating human liposarcoma","volume":"10","author":"Wang","year":"2011","journal-title":"Mol. Cancer Ther."},{"issue":"10066","key":"10.1016\/j.lfs.2026.124358_bb0290","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.lfs.2026.124358_bb0295","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.lfs.2026.124358_bb0300","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ccell.2021.03.010","article-title":"Targeting cell-cycle machinery in cancer","volume":"39","author":"Suski","year":"2021","journal-title":"Cancer Cell"},{"issue":"34","key":"10.1016\/j.lfs.2026.124358_bb0305","doi-asserted-by":"crossref","first-page":"20608","DOI":"10.1074\/jbc.271.34.20608","article-title":"Cyclin D1 expression is regulated positively by the p42\/p44(MAPK) and negatively by the p38\/HOG(MAPK) pathway","volume":"271","author":"Lavoie","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.lfs.2026.124358_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003065","article-title":"Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling","volume":"3","author":"She","year":"2008","journal-title":"PloS One"},{"issue":"7074","key":"10.1016\/j.lfs.2026.124358_bb0315","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nature04304","article-title":"BRAF mutation predicts sensitivity to MEK inhibition","volume":"439","author":"Solit","year":"2006","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.lfs.2026.124358_bb0320","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/nm.2941","article-title":"Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma","volume":"18","author":"Kwong","year":"2012","journal-title":"Nat. Med."},{"issue":"18","key":"10.1016\/j.lfs.2026.124358_bb0325","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1158\/0008-5472.CAN-22-0198","article-title":"Targeting RAS mutant colorectal cancer with dual inhibition of MEK and CDK4\/6","volume":"82","author":"Sorokin","year":"2022","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.lfs.2026.124358_bb0330","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.3892\/or.2017.5528","article-title":"High ATP2A2 expression correlates with better prognosis of diffuse astrocytic tumor patients","volume":"37","author":"Li","year":"2017","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2026.124358_bb0335","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1046\/j.1523-1747.2003.12410.x","article-title":"Mutations in the sarcoplasmic\/endoplasmic reticulum Ca2+ ATPase isoform cause Darier\u2019s disease","volume":"121","author":"Dhitavat","year":"2003","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.lfs.2026.124358_bb0340","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ccr.2013.01.015","article-title":"Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancer","volume":"23","author":"Roti","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2026.124358_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217075","article-title":"Novel SERCA2 inhibitor Diphyllin displays anti-tumor effect in non-small cell lung cancer by promoting endoplasmic reticulum stress and mitochondrial dysfunction","volume":"598","author":"Xu","year":"2024","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.lfs.2026.124358_bb0350","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.7150\/ijbs.82361","article-title":"PTPLAD1 regulates PHB-Raf interaction to orchestrate epithelial-mesenchymal and mitofusion-fission transitions in colorectal cancer","volume":"20","author":"Huang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.lfs.2026.124358_bb0355","article-title":"Fatty acid dehydratase HACD3 poses protein kinase activity and promotes the malignant progression of colorectal cancer","volume":"283","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124358_bb0360","article-title":"HACD3 promotes malignant progression of NSCLC by suppressing the MKK7\/MAPK10 signaling axis","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Cancer"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526001670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526001670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:11:47Z","timestamp":1778944307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320526001670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":72,"alternative-id":["S0024320526001670"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124358","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Membrane protein-focused CRISPR screen identifies ATP2A2 as a druggable transcriptional co-regulator of CCND1 (cyclin D1) in lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124358"}}